Publication | Closed Access

Designed P-glycoprotein inhibitors with triazol-tetrahydroisoquinoline-core increase doxorubicin-induced mortality in multidrug resistant K562/A02 cells

BiochemistryMedicineP-glycoprotein InhibitorsPharmacotherapyAntimicrobial ChemotherapyAnti-cancer AgentDrug DevelopmentPharmacologyDrug DiscoveryDrug Resistance